AKIRAM THERAPEUTICS
Akiram Therapeutics is a Swedish biotech company focused on the development of targeted radioimmunotherapy for cancer, which is based on a proprietary antibody targeting the cancer marker CD44v6 combined with a radiation component. The therapy has generated strong preclinical results in cancer models in conditions that currently lack effective treatments. With the potential for its drug candidate to be classified as an orphan drug and recognized as first-in-class, the company is dedicated to adv... ancing research in this field, including indications in head and neck cancer, AML (Acute Myeloid Leukemia), lung cancer, and aggressive thyroid cancer. Headquartered in Uppsala, Sweden, Akiram Therapeutics is staffed with experts in radiation science research, cancer precision medicine, and drug development.
AKIRAM THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Precision Medicine
Founded:
2021-06-10
Address:
Uppsala, Uppsala Lan, Sweden
Country:
Sweden
Website Url:
http://www.akiramtherapeutics.se
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
67.88 M SEK
Technology used in webpage:
Japanese Yen Team.blue
Similar Organizations
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Immunitas Therapeutics
Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Pheast Therapeutics
Pheast Therapeutics develops novel checkpoint therapies to harness the innate immune system.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Founder
Investors List
Sciety
Sciety investment in Venture Round - Akiram Therapeutics
Official Site Inspections
http://www.akiramtherapeutics.se
- Host name: linux202.unoeuro.com
- IP address: 93.191.156.77
- Location: Langeskov Denmark
- Latitude: 55.3565
- Longitude: 10.5845
- Timezone: Europe/Copenhagen
- Postal: 5550
More informations about "Akiram Therapeutics"
Akiram Therapeutics – Advancing radiotherapeutics to …
Apr 3, 2025 E-mail us at [email protected] Akiram Therapeutics is a Swedish biotech company committed to developing innovative and targeted molecular radiotherapy for patients with incurable cancer. Our product …See details»
About - Akiram Therapeutics
Akiram Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Akiram Therapeutics is a Swedish biotech company focused on the development of targeted …See details»
Our Team - Akiram Therapeutics
E-mail us at [email protected] Akiram Therapeutics is a Swedish biotech company committed to developing innovative and targeted molecular radiotherapy for patients with …See details»
Akiram Therapeutics 2025 Company Profile: Valuation, Funding ...
Akiram Therapeutics General Information Description. Developer of radiopharmaceuticals designed for advancing radio therapeutics to treat solid tumors. The company is focused on …See details»
Akiram Therapeutics AB | Aktiebolag | Info & Löner - Bolagsfakta
Akiram Therapeutics AB – Org.nummer: 559338-7458. På Bolagsfakta.se hittar du kontakt-och företagsinformation, nyckeltal, lön till VD & styrelse m.m.See details»
Akiram Therapeutics AB - Företagsinformation - allabolag.se
Akiram Therapeutics AB,559338-7458 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, Status, adress mm för Akiram Therapeutics ABSee details»
Akiram Therapeutics - VentureRadar
Website: http://akiramtherapeutics.se/ Develops next generation radiopharmaceuticals for efficient visualization and treatment of solid cancers using novel ...See details»
Akiram Therapeutics - LinkedIn
Akiram Therapeutics is a Swedish biotech company committed to developing innovative and targeted molecular radiotherapy for patients with incurable cancer.See details»
Akiram Therapeutics AB - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Akiram Therapeutics AB of Uppsala, Uppsala. Get the latest business insights from Dun & Bradstreet.See details»
Akiram Therapeutics - Cision News
Akiram Therapeutics is a Swedish biotech company focused on the development of targeted radioimmunotherapy for cancer, which is based on a proprietary antibody targeting the cancer …See details»
Akiram Therapeutics raises SEK 68 million for clinical development …
Jan 12, 2023 Email: [email protected] Phone: +46 702 34 18 81. About Akiram Therapeutics Akiram Therapeutics is a Swedish biotech company focused on the …See details»
Akiram Therapeutics - Products, Competitors, Financials, …
Akiram Therapeutics to Showcase Key Data on AKIR001 at Targeted Radiopharmaceuticals Summit Europe 2024. Nov 28, 2024. Akiram Therapeutics Thu, Nov 28, 2024 07:05 CET …See details»
Akiram Therapeutics initiates Eurostars-funded collaboration to …
Apr 3, 2025 Email: [email protected] About Akiram Therapeutics Akiram Therapeutics is a Swedish biotechnology company in clinical phase developing innovative …See details»
Akiram Therapeutics - Drug Discovery World (DDW)
Oct 14, 2024 Akiram Therapeutics will reveal its research findings on radioimmunotherapy drug candidate AKIR001 at the European Association of Nuclear Medicine (EANM) Congress 2024 …See details»
Akiram Therapeutics initiates Eurostars-funded collaboration to …
6 days ago Email: [email protected]. About Akiram Therapeutics Akiram Therapeutics is a Swedish biotech company focused on the development of targeted …See details»
Akiram tar in finansiering för ny typ av strålterapi
Jan 12, 2023 Se senaste nyhetsbrev; See latest newsletter from Medtech Magazine Hjälpmedel; Hjälpmedel Medlemsnytt Företag Våra event. Köp en prenumeration Medlem Registrera …See details»
SciLifeLab DDD exit spin-off Akiram Therapeutics to start clinical ...
Nov 7, 2024 Akiram Therapeutics, a spin-off company based on SciLifeLab researcher Marika Nestor’s 2022 Drug Discovery and Development Platform (DDD) exit, has received approval …See details»
News - Akiram Therapeutics
Oct 9, 2024 Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, will participate in the European Association of Nuclear Medicine (EANM) …See details»
Our Therapy – Akiram Therapeutics
Akiram is leading the development of molecular radiotherapy as a novel treatment for CD44v6 expressing cancers. This innovative approach has demonstrated exceptional efficacy in …See details»